Using AI to create libraries for chemical synthesis
Generative AI for retrosynthesis libraries
This study is exploring new ways to use artificial intelligence to help scientists break down complex molecules into simpler parts, which could speed up the creation of new medicines that might help patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11009576 on NIH RePORTER |
What this research studies
This research focuses on developing advanced artificial intelligence techniques to improve the process of retrosynthesis, which is the method of breaking down complex molecules into simpler components for drug development. By utilizing generative AI, the project aims to create diverse libraries of synthetic reactions that can efficiently produce target molecules through one-step reactions. The approach involves innovative deep learning methods, specifically graph neural networks, to accurately represent molecular structures and automate the synthesis process. Patients may benefit indirectly from this research as it could lead to faster and more effective drug discovery.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that require new drug therapies or those involved in clinical trials for novel medications.
Not a fit: Patients who are not seeking new treatments or those with conditions that are already well-managed with existing therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly accelerate the development of new drugs, leading to improved treatment options for patients.
How similar studies have performed: Other research has shown promise in using AI for drug discovery, indicating that this approach could lead to significant advancements in the field.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Ning, Xia — Ohio State University
- Study coordinator: Ning, Xia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.